Evidence map›Paper›PMID 31381312›Full record

ArticleJournal of the American Chemical Society2019

MftD Catalyzes the Formation of a Biologically Active Redox Center in the Biosynthesis of the Ribosomally Synthesized and Post-translationally Modified Redox Cofactor Mycofactocin.

Richard S Ayikpoe, John A Latham

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel aspects of ethylene glycol catabolism.Applied microbiology and biotechnology · 2024
    Review
  5. Review
  6. ACS chemical biology · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Impact of Oxygen Supply and Scale Up onFrontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Richard S AyikpoeDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80210 , United States.
John A LathamDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80210 , United States.ORCID 0000-0002-3034-1768
University of Denver · US

Funding

Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosisR01GM124002 · NIGMS · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, SANDRA S. · 2017 to 2021
$1.6M
NIGMS NIH HHS R01 GM124002
6 · The paper itself

Abstract

Mycofactocin (MFT) is a putative ribosomally synthesized and post-translationally modified (RiPP) redox cofactor. The biosynthesis of MFT is encoded by the gene cluster

Indexed as

Bacterial ProteinsDeaminationHumansMycobacterium Infections, NontuberculousMycobacterium smegmatisOxidation-ReductionOxidoreductasesPeptidesProtein Processing, Post-TranslationalRibosomesBacterial ProteinsOxidoreductasesPeptides

Identifiers

PMID31381312
PMCPMC6716157
OpenAlexW2965649016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.